Ardent Health (ARDT) Competitors

$10.11 -0.21 (-2.00%)

Closing price 05/15/2026 03:59 PM Eastern

Extended Trading

$10.11 0.00 (-0.04%)

As of 05/15/2026 05:28 PM Eastern

ARDT vs. CAI, PACS, RDNT, SHC, and BLLN

Should you buy Ardent Health stock or one of its competitors? MarketBeat compares Ardent Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Ardent Health include Caris Life Sciences (CAI), PACS Group (PACS), RadNet (RDNT), Sotera Health (SHC), and Billiontoone (BLLN). These companies are all part of the "healthcare" industry.

How does Ardent Health compare to Caris Life Sciences?

Caris Life Sciences (NASDAQ:CAI) and Ardent Health (NYSE:ARDT) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends, media sentiment and valuation.

Caris Life Sciences currently has a consensus price target of $27.56, indicating a potential upside of 89.39%. Ardent Health has a consensus price target of $14.21, indicating a potential upside of 40.48%. Given Caris Life Sciences' stronger consensus rating and higher probable upside, equities analysts clearly believe Caris Life Sciences is more favorable than Ardent Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Caris Life Sciences	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50
Ardent Health	2 Sell rating(s)	5 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.36

Caris Life Sciences has a net margin of 3.75% compared to Ardent Health's net margin of 2.09%. Caris Life Sciences' return on equity of 98.28% beat Ardent Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Caris Life Sciences	3.75%	98.28%	48.87%
Ardent Health	2.09%	13.85%	4.48%

Ardent Health has higher revenue and earnings than Caris Life Sciences. Caris Life Sciences is trading at a lower price-to-earnings ratio than Ardent Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Caris Life Sciences	$812.03M	5.07	-$68.09M	-$7.61	N/A
Ardent Health	$6.32B	0.23	$135.81M	$0.95	10.65

In the previous week, Caris Life Sciences had 5 more articles in the media than Ardent Health. MarketBeat recorded 9 mentions for Caris Life Sciences and 4 mentions for Ardent Health. Ardent Health's average media sentiment score of 0.39 beat Caris Life Sciences' score of 0.31 indicating that Ardent Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Caris Life Sciences	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
Ardent Health	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Caris Life Sciences beats Ardent Health on 7 of the 13 factors compared between the two stocks.

How does Ardent Health compare to PACS Group?

PACS Group (NYSE:PACS) and Ardent Health (NYSE:ARDT) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends, media sentiment and valuation.

PACS Group currently has a consensus price target of $45.60, indicating a potential upside of 21.48%. Ardent Health has a consensus price target of $14.21, indicating a potential upside of 40.48%. Given Ardent Health's higher probable upside, analysts clearly believe Ardent Health is more favorable than PACS Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PACS Group	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.67
Ardent Health	2 Sell rating(s)	5 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.36

PACS Group has a beta of -0.03, indicating that its share price is 103% less volatile than the broader market. Comparatively, Ardent Health has a beta of 0.93, indicating that its share price is 7% less volatile than the broader market.

PACS Group has a net margin of 4.49% compared to Ardent Health's net margin of 2.09%. PACS Group's return on equity of 26.47% beat Ardent Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PACS Group	4.49%	26.47%	4.36%
Ardent Health	2.09%	13.85%	4.48%

PACS Group has higher earnings, but lower revenue than Ardent Health. Ardent Health is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PACS Group	$5.29B	1.12	$191.54M	$1.56	24.06
Ardent Health	$6.32B	0.23	$135.81M	$0.95	10.65

In the previous week, PACS Group had 10 more articles in the media than Ardent Health. MarketBeat recorded 14 mentions for PACS Group and 4 mentions for Ardent Health. PACS Group's average media sentiment score of 0.80 beat Ardent Health's score of 0.39 indicating that PACS Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PACS Group	6 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Ardent Health	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

PACS Group beats Ardent Health on 9 of the 14 factors compared between the two stocks.

How does Ardent Health compare to RadNet?

Ardent Health (NYSE:ARDT) and RadNet (NASDAQ:RDNT) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, valuation, institutional ownership, media sentiment, analyst recommendations, dividends and profitability.

Ardent Health has a beta of 0.93, suggesting that its stock price is 7% less volatile than the broader market. Comparatively, RadNet has a beta of 1.43, suggesting that its stock price is 43% more volatile than the broader market.

Ardent Health has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than Ardent Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ardent Health	$6.32B	0.23	$135.81M	$0.95	10.65
RadNet	$2.14B	1.92	-$18.65M	-$0.18	N/A

Ardent Health has a net margin of 2.09% compared to RadNet's net margin of -0.66%. Ardent Health's return on equity of 13.85% beat RadNet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ardent Health	2.09%	13.85%	4.48%
RadNet	-0.66%	2.77%	0.97%

Ardent Health presently has a consensus price target of $14.21, indicating a potential upside of 40.48%. RadNet has a consensus price target of $88.14, indicating a potential upside of 68.24%. Given RadNet's stronger consensus rating and higher possible upside, analysts clearly believe RadNet is more favorable than Ardent Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ardent Health	2 Sell rating(s)	5 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.36
RadNet	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.90

In the previous week, RadNet had 9 more articles in the media than Ardent Health. MarketBeat recorded 13 mentions for RadNet and 4 mentions for Ardent Health. Ardent Health's average media sentiment score of 0.39 beat RadNet's score of 0.25 indicating that Ardent Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Ardent Health	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
RadNet	2 Very Positive mention(s)	3 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

77.9% of RadNet shares are held by institutional investors. 1.9% of Ardent Health shares are held by company insiders. Comparatively, 5.6% of RadNet shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Ardent Health beats RadNet on 9 of the 17 factors compared between the two stocks.

How does Ardent Health compare to Sotera Health?

Sotera Health (NASDAQ:SHC) and Ardent Health (NYSE:ARDT) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, media sentiment, earnings, analyst recommendations, risk, profitability and valuation.

Sotera Health has a net margin of 9.91% compared to Ardent Health's net margin of 2.09%. Sotera Health's return on equity of 39.73% beat Ardent Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sotera Health	9.91%	39.73%	7.05%
Ardent Health	2.09%	13.85%	4.48%

In the previous week, Sotera Health had 2 more articles in the media than Ardent Health. MarketBeat recorded 6 mentions for Sotera Health and 4 mentions for Ardent Health. Sotera Health's average media sentiment score of 0.56 beat Ardent Health's score of 0.39 indicating that Sotera Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sotera Health	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Ardent Health	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Sotera Health has a beta of 1.82, meaning that its share price is 82% more volatile than the broader market. Comparatively, Ardent Health has a beta of 0.93, meaning that its share price is 7% less volatile than the broader market.

Sotera Health currently has a consensus target price of $20.33, indicating a potential upside of 33.16%. Ardent Health has a consensus target price of $14.21, indicating a potential upside of 40.48%. Given Ardent Health's higher possible upside, analysts plainly believe Ardent Health is more favorable than Sotera Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.70
Ardent Health	2 Sell rating(s)	5 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.36

91.0% of Sotera Health shares are owned by institutional investors. 15.4% of Sotera Health shares are owned by insiders. Comparatively, 1.9% of Ardent Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Ardent Health has higher revenue and earnings than Sotera Health. Ardent Health is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sotera Health	$1.16B	3.74	$77.94M	$0.41	37.24
Ardent Health	$6.32B	0.23	$135.81M	$0.95	10.65

Summary

Sotera Health beats Ardent Health on 11 of the 15 factors compared between the two stocks.

How does Ardent Health compare to Billiontoone?

Billiontoone (NASDAQ:BLLN) and Ardent Health (NYSE:ARDT) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, media sentiment, earnings, analyst recommendations, risk, profitability and valuation.

Ardent Health has higher revenue and earnings than Billiontoone. Ardent Health is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Billiontoone	$305.11M	12.46	$7.45M	$0.55	150.24
Ardent Health	$6.32B	0.23	$135.81M	$0.95	10.65

Ardent Health has a net margin of 2.09% compared to Billiontoone's net margin of 0.00%. Ardent Health's return on equity of 13.85% beat Billiontoone's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Billiontoone	N/A	N/A	N/A
Ardent Health	2.09%	13.85%	4.48%

In the previous week, Billiontoone had 1 more articles in the media than Ardent Health. MarketBeat recorded 5 mentions for Billiontoone and 4 mentions for Ardent Health. Billiontoone's average media sentiment score of 0.41 beat Ardent Health's score of 0.39 indicating that Billiontoone is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Billiontoone	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Ardent Health	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Billiontoone currently has a consensus target price of $125.29, indicating a potential upside of 51.62%. Ardent Health has a consensus target price of $14.21, indicating a potential upside of 40.48%. Given Billiontoone's stronger consensus rating and higher possible upside, equities research analysts plainly believe Billiontoone is more favorable than Ardent Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50
Ardent Health	2 Sell rating(s)	5 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.36

Summary

Ardent Health beats Billiontoone on 7 of the 13 factors compared between the two stocks.

Get Ardent Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ARDT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ARDT vs. The Competition

Export

Metric	Ardent Health	Medical Services Industry	Medical Sector	NYSE Exchange
Market Cap	$1.48B	$8.29B	$6.42B	$22.98B
Dividend Yield	N/A	3.05%	2.80%	4.09%
P/E Ratio	10.65	21.86	20.38	29.75
Price / Sales	0.23	20.67	566.15	14.09
Price / Cash	3.75	80.56	43.04	25.31
Price / Book	0.84	5.45	9.87	4.60
Net Income	$135.81M	$183.43M	$3.57B	$1.07B
7 Day Performance	-0.16%	-1.16%	0.31%	-2.27%
1 Month Performance	6.76%	0.47%	-1.27%	-0.37%
1 Year Performance	-34.34%	-0.37%	33.54%	21.80%

Ardent Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ARDT Ardent Health	3.7802 of 5 stars	$10.11 -2.0%	$14.21 +40.5%	-33.7%	$1.48B	$6.32B	10.65	25,200	Analyst Upgrade
CAI Caris Life Sciences	4.3426 of 5 stars	$18.38 -1.6%	$28.86 +57.0%	N/A	$5.20B	$812.03M	N/A	1,846	Insider Trade
PACS PACS Group	3.8308 of 5 stars	$32.79 +0.8%	$44.40 +35.4%	+253.1%	$5.16B	$5.29B	26.67	47,455	Earnings Report Analyst Forecast
RDNT RadNet	3.1879 of 5 stars	$58.76 +0.9%	$88.14 +50.0%	-13.1%	$4.61B	$2.04B	N/A	11,264	Earnings Report Analyst Downgrade Gap Up
SHC Sotera Health	3.6995 of 5 stars	$14.51 -5.7%	$20.67 +42.4%	+19.9%	$4.14B	$1.16B	53.80	3,000	Insider Trade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:ARDT) was last updated on 5/16/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Ardent Health (ARDT) Competitors

ARDT vs. CAI, PACS, RDNT, SHC, and BLLN

How does Ardent Health compare to Caris Life Sciences?

Summary

How does Ardent Health compare to PACS Group?

Summary

How does Ardent Health compare to RadNet?

Summary

How does Ardent Health compare to Sotera Health?

Summary

How does Ardent Health compare to Billiontoone?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ARDT vs. The Competition

Ardent Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Ardent Health (ARDT) Competitors

ARDT vs. CAI, PACS, RDNT, SHC, and BLLN

How does Ardent Health compare to Caris Life Sciences?

Do analysts recommend CAI or ARDT?

Is CAI or ARDT more profitable?

Which has preferable earnings & valuation, CAI or ARDT?

Does the media favor CAI or ARDT?

Summary

How does Ardent Health compare to PACS Group?

Do analysts recommend PACS or ARDT?

Which has more volatility and risk, PACS or ARDT?

Is PACS or ARDT more profitable?

Which has preferable earnings & valuation, PACS or ARDT?

Does the media prefer PACS or ARDT?

Summary

How does Ardent Health compare to RadNet?

Which has more volatility and risk, ARDT or RDNT?

Which has stronger valuation and earnings, ARDT or RDNT?

Is ARDT or RDNT more profitable?

Do analysts rate ARDT or RDNT?

Does the media favor ARDT or RDNT?

Do institutionals & insiders have more ownership in ARDT or RDNT?

Summary

How does Ardent Health compare to Sotera Health?

Is SHC or ARDT more profitable?

Does the media refer more to SHC or ARDT?

Which has more risk & volatility, SHC or ARDT?

Do analysts recommend SHC or ARDT?

Do insiders & institutionals have more ownership in SHC or ARDT?

Which has preferable valuation & earnings, SHC or ARDT?

Summary

How does Ardent Health compare to Billiontoone?

Which has preferable valuation & earnings, BLLN or ARDT?

Is BLLN or ARDT more profitable?

Does the media prefer BLLN or ARDT?

Do analysts recommend BLLN or ARDT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ARDT vs. The Competition

Ardent Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools